Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (51-60 of 134) with videos related to

Pageof 14
Sort By:
The Journal of Investigative Dermatology|May 18, 2007
Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID miceChristiane Thallinger, Johannes Werzowa, Wolfgang Poeppl, et al.
Thrombosis Research|December 1, 2015
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependentPetra Jilma-Stohlawetz, Peter Quehenberger, Heinrich Schima, et al.
Thrombosis and Haemostasis|September 6, 2006
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancyGuelay Alguel, Rainer Vormittag, Ralph Simanek, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis and Haemostasis|April 30, 2003
The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolismVerena Schönauer, Sandra Giannini, Günter Christ, et al.
BMC Medicine|March 11, 2017
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulantFlorian Posch, Johanna Gebhart, Jacob H Rand, et al.
Thrombosis and Haemostasis|April 15, 2016
Lupus-anticoagulant testing at NOAC trough levelsFranz Ratzinger, Mona Lang, Sabine Belik, et al.
Thrombosis Research|September 28, 2010
An experimental model to study isolated effects of thrombin in vivoJolanta M Siller-Matula, Guenther Bayer, Helga Bergmeister, et al.
Thrombosis Research|February 17, 2007
The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivoFlorian M Kovar, Claudia Marsik, Bernd Jilma, et al.
Haematologica|April 16, 2013
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyBoris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Pageof 14

Showing results (51-60 of 134) with videos related to

Sort By:
Pageof 14
The Journal of Investigative Dermatology|May 18, 2007
Comparison of a treatment strategy combining CCI-779 plus DTIC versus DTIC monotreatment in human melanoma in SCID miceChristiane Thallinger, Johannes Werzowa, Wolfgang Poeppl, et al.
Thrombosis Research|December 1, 2015
Acquired von Willebrand factor deficiency caused by LVAD is ADAMTS-13 and platelet dependentPetra Jilma-Stohlawetz, Peter Quehenberger, Heinrich Schima, et al.
Thrombosis and Haemostasis|September 6, 2006
Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancyGuelay Alguel, Rainer Vormittag, Ralph Simanek, et al.
Thrombosis and Haemostasis|January 4, 2007
Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancerGregor Hron, Marietta Kollars, Heinz Weber, et al.
Thrombosis and Haemostasis|April 30, 2003
The effect of beta-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolismVerena Schönauer, Sandra Giannini, Günter Christ, et al.
BMC Medicine|March 11, 2017
Cardiovascular risk factors are major determinants of thrombotic risk in patients with the lupus anticoagulantFlorian Posch, Johanna Gebhart, Jacob H Rand, et al.
Thrombosis and Haemostasis|April 15, 2016
Lupus-anticoagulant testing at NOAC trough levelsFranz Ratzinger, Mona Lang, Sabine Belik, et al.
Thrombosis Research|September 28, 2010
An experimental model to study isolated effects of thrombin in vivoJolanta M Siller-Matula, Guenther Bayer, Helga Bergmeister, et al.
Thrombosis Research|February 17, 2007
The fibrinogen -148 C/T polymorphism influences inflammatory response in experimental endotoxemia in vivoFlorian M Kovar, Claudia Marsik, Bernd Jilma, et al.
Haematologica|April 16, 2013
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyBoris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Pageof 14